Is there a recreational misuse potential for Pregabalin? : Analysis of anecdotal online reports in comparison with related Gabapentin and Clonazepam data by Schifano, Fabrizio et al.
 1 
IS THERE A RECREATIONAL MISUSE POTENTIAL FOR 
PREGABALIN? ANALYSIS OF ANECDOTAL ONLINE REPORTS IN COMPARISON 
WITH RELATED GABAPENTIN AND CLONAZEPAM DATA 
 
FABRIZIO SCHIFANO1, STEFANO D‘OFFIZI 1,2, MICHELE PICCIONE2, ORNELLA 
CORAZZA1,3, PAOLO DELUCA3, ZOE DAVEY3, GIUDITTA DI MELCHIORRE1, LUCIA DI 
FURIA4, MAGI‘ FARRE5, LIV FLESLAND6, MIIA MANNONEN7, AINO MAJAVA7, STEFANIA 
PAGANI4, TEUVO PELTONIEMI7, HOLGER SIEMANN8, ARVID SKUTLE6, MARTA 
TORRENS5, CINZIA PEZZOLESI1, PEER VAN DER KREEFT9, NORBERT SCHERBAUM8 
 
 
1
 „ReDNet‟ and „Psychonaut Web Mapping‟ Projects; University of Hertfordshire School of Pharmacy, Hatfield, UK 
2 
Psychiatry and Clinical Psychology Department, Umberto I, “La Sapienza” University of Rome Medical School, Rome, Italy; Viale 
Regina Elena 244, 00161, Rome,Italy; doffizi.stefano@gmail.com; michele.piccione@uniroma1.it
 
3
 Psychonaut Web Mapping Project; National Addiction Centre, Institute of Psychiatry, King's College London, London, UK; 4 Windsor 
Walk; SE5 AF; paolo.deluca@kcl.ac.uk; zoe.davey@kcl.ac.uk 
4
 Psychonaut Web Mapping Project; Servizio Salute Regione Marche, Ancona, Italy; Assessorato Salute Regione Marche. Address. Via 
Gentile da Fabriano 3. Ancona 60100; lucia.difuria@regione.marche.it; stefy.pagani@gmail.com 
5 
Psychonaut Web Mapping Project; IAPS-IMIM-Hospital del Mar-UAB, Barcelona, Spain; Passeig Marítim 25-29. Barcelona 08003; 
MTorrens@imim.es; Mfarre@imim.es 
6 
Psychonaut Web Mapping Project; Bergen Clinics Foundation, Centre of Competence, Bergen, Norway; Vestre Torggate 11 -
 5015 Bergen; arvid.skutle@bergenclinics.no; liv.holmefjord.flesland@bergenclinics.no  
7 
Psychonaut Web Mapping Project; A-Clinic Foundation, Department of Communications, Helsinki, Finland; Paasivuorenkatu 2A; 
00530; Helsinki; teuvo.peltoniemi@a-klinikka.fi; aino.majava@a-klinikka.fi; miia.mannonen@a-klinikka.fi 
8 
Psychonaut Web Mapping Project; Addiction Research Group at the Department of Psychiatry and Psychotherapy, LVR-Hospital 
Essen, Hospital of the University Duisburg-Essen, Germany; Virchowstraße 174. D-45122 Essen; norbert.scherbaum@uni-due.de; 
holger.siemann@lvr.de 
9
 Psychonaut Web Mapping Project; De Sleutel Technische Bedrijfseen heid Provincialaat der Broeders van Liefde, Merelbeke, Jozef 
Guislainstraat 43 a; B-9000; Gent Belgium; peer.van.der.kreeft@fracarita.org 
 
  
 
Text: 989 words 
 
 
 
 
 
 
 
 
Corresponding author:  
 
Professor Fabrizio Schifano 
Chair in Clinical Pharmacology and Therapeutics 
Associate Dean, Postgraduate Medical School 
Consultant Psychiatrist (Addictions) 
University of Hertfordshire 
School of Pharmacy 
College Lane Campus 
Hatfield, Herts 
AL10 9AB (UK) 
telephone: +44 (0)1707-286107 
fax: +44 (0)1707-284506 
mobile: +44 (0)778 900 6809  
email: F.Schifano@herts.ac.uk 
 
 
 
 
 
 2 
ABSTRACT  
 
 
 
Background: Although pregabalin abuse potential is reportedly low, online data related to its 
recreational misuse potential have recently been identified. We aimed here at formally 
analysing pregabalin misuse web reports and comparing these with data pertaining to similar 
drugs, e.g. gabapentin and clonazepam, for which an abuse potential has already been 
identified. 
 
Methods: An 8-language analysis of the online information on pregabalin acquisition/misuse 
was carried out. An initial sample of 203 websites was considered and 108 relevant websites 
were monitored on a regular basis. To obtain material relating to gabapentin and clonazepam, 
an English-language search was carried out and 32 relevant websites were examined.  
 
Results: Misuse of pregabalin, which is commonly offered for sale online, was allegedly 
associated with sedative and/or psychedelic effects. This was associated with both higher 
dosages than clinically advised and idiosyncratic (i.e.: IV, rectal, intranasal) drug intake 
modalities. Although perceived as less powerful than pregabalin, gabapentin misuse was 
associated with similar sedative/psychedelic effects. Clonazepam allegedly induced either 
sedation or stimulation, depending on the dosage. 
   
Conclusions: Pregabalin experimenters might be profiled as individuals with a history of 
recreational polydrug misuse. Pregabalin misuse might be  facilitated by easy online 
accessibility; potency; and peculiar, including anxiolytic, psychoactive effects. Physicians 
should carefully evaluate patients for history of drug abuse and observe them for signs of 
pregabalin/gabapentin/clonazepam misuse. 
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Introduction 
With online pharmacies, prescription drugs may be more widely accessible (1-3). In particular, 
preliminary online information pertaining to both pregabalin purchase availability and its 
recreational misuse potential has been recently identified (4). Pregabalin is a prescription drug 
licensed to treat generalized anxiety disorder; partial epilepsy; and neuropathic pain. Since its 
misuse potential is reportedly low (5-7), we aimed here at formally analysing both pregabalin 
misuse anecdotal online reports and its online purchase availability levels. Pregabalin data 
were here compared with related clonazepam and gabapentin online information. In fact, 
pregabalin is structurally related to gabapentin (8), and shares some therapeutic indications 
with clonazepam. Interestingly, both clonazepam (9-11) and gabapentin (12-13) possess an 
identified abuse potential, at least in selected populations.  
 
Materials and methods 
Between January 2008 and August 2010, qualitative Google searches of 203 websites have 
been carried out in 8 European languages (English, German, Spanish, Italian, Dutch, 
Norwegian, Finnish, Swedish) using keywords such as ‗legal highs‘; ‗research chemicals‘;  
‗online pharmacy‘; ‗Lyrica‘; ‗pregabalin‘; and ‗online pharmacies‘. Out of these, 108 websites 
were monitored on a regular basis, i.e. daily (n=21), weekly (n=32), monthly (n=55), 
depending on relevance; the remaining 95 websites were not considered here to be relevant. 
To obtain material relating to gabapentin and clonazepam, the Google search was carried out 
in English, with 52 websites examined and 32 identified as relevant. Links from above 
websites/forums, and other related material were followed as well. The SW London/St 
George‘s Ethics Committee granted the study permission. 
 
Results 
Pregabalin was here described as an ‗ideal psychotropic drug‘ for recreational purposes to 
achieve specific mindsets, including: alcohol/GHB/benzodiazepine-like effects mixed with 
euphoria; to achieve entactogenic feelings and DXM-like disassociation; and to cope with 
opiates/opioids‘ withdrawal (Table 1). A pregabalin vs gabapentin experimentation YouTube 
video (14) was here identified as well. Misuse of pregabalin mostly seemed to occur orally, but 
IV; rectal (‗plugging‘); and ‗parachuting‘ (emptying the content of the capsule into a pouch) 
self-administration techniques were also reported. Time of onset of the effects ranged here 
between 10mins-2hours, depending on the route of administration. Tolerance may reportedly 
develop fairly rapidly, to wear off quickly after drug cessation.  
Similarly, gabapentin seemed to possess both heavy sedative (‗..it‘s like I‘m on a fully-sedated 
opiate buzz....‘) and psychedelic (‗..I feel a disassociation much like DXM...‘; ‗...1200mgs+ has 
me in an off buzz slightly reminiscent of MDMA….‘) effects. Interestingly, however, one user 
argued that ‗pregabalin outshines gabapentin. Far less dosage to achieve the same 
recreational high....‘. Similarly to pregabalin, drug tolerance could reportedly develop very 
rapidly.  
Conversely, clonazepam was reportedly inducing either sedation (at 1-2 mg) or stimulation (at 
more than 8 mg). Clonazepam was typically co-administered with different sedatives and/or 
psychedelics. Pregabalin, gabapentin and clonazepam were commonly offered for sale on the 
web, without the need of a prescription. 
 
Table 1: Summary of online alleged users’ accounts of pregabalin, gabapentin and 
clonazepam misuse 
Comments 
on dosages 
taken and 
the 
allegedly 
achieved 
psychoacti
ve effects  
According to pregabalin (mis)users, different dosages are associated with a vast range of effects:   
“....600mg: stumbling, disorientation, increased physic and psychological awareness, difficulty to 
drive, slurred and broken speech, hearing and visual alterations/hallucinations, double and blurred 
vision, uninhibited behaviours, talkativeness, increased body energy, increased sexual performances. 
900mg: strong feelings of drunkenness, difficulty to walk, alteration of colours perception, little 
euphoria. 
1200mg: drowsiness, euphoria, entactogenetic feelings. 
>1500mg (to 5 g): uncontrollable drowsiness, frequent hallucinations, great euphoria, frequent 
dissociative events (described like dextromethorphan/DXM-like dissociative effects), behavioural 
inhibition, anxiety, and necessity to move...‖ (15) 
 
 ―I am interested in using it to combat heroin withdrawals‖ (16) 
 
―……the pregabalin erases my benzo, opiate withdrawal and cravings… IMO anything over 900 mg is a 
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waste - too sedating.‖ (17) 
 
―SWIdr has tried Pregabalin .. He seemed very relaxed (anxiety free), not too much euphoria but 
some, DXM dissociative-like effects....‖ (15) 
 
―Yes, it is similar to a benzo high......I would say it is more similar to GHB...‖ (16) 
  
Gabapentin 
―...The most I have done has been 4800mg of the 600mg pills whilst the lowest amount that I can 
take to get any effect seems to be around 900mg or more.... To classify this pharm is a near 
impossible task. It is everything and anything in one pill. The only downside to gabapentin so far as I 
can tell, is the onset. These little guys take upwards of an hour to really start to kick in, but luckily, 
they last for 4-8 hours it seems........ I feel as if I‘m on a super amphetamine rush and can tackle 
anything, yet feel so content it‘s like I‘m on a fully-sedated opiate buzz. I‘m chatty and witty, deep 
and insightful....‖ (18) 
 
―.. I knew that I need at least 10 300's to get the right effect. Most everyone else I know that takes 
gapapentin take only 7 or 8... so about an hour taking after them I feel a disassociation much like 
DXM, but only in my head and hands. My worries started to fade away. I am a very quiet, shy person 
normally, but when I am on gabapentin after about 1.5 hours I get very friendly, very talkative, very 
active, very uninhibited... You really need to walk around on gabapentin dancing would be 
incredible...‖  (19) 
 
―......The feeling was comparable to cannabis with more of a heavy feeling in the body....‖ (20)  
 
Pregabalin vs gabapentin recreational psychoactive effects 
 ―...In my opinion, pregabalin outshines gabapentin. Far less dosage to achieve the same recreational 
high. Also not as strong of a half life allowing one to use the drug more frequently (ie. every 
weekend)....‖ (20) 
Clonazepam  
Most reports suggest 1-2 mg to achieve sedation; euphoria is achieved by increasing the dose to 8-
12 mg; ―… About 10 minutes after insufflation, I noticed a high or buzz much like that I remember 
when I was being sedated before dental surgery. It was very pleasant, and I felt very relaxed….‖ (21) 
―At first I felt a bit disorientated, some kind of anguish were crawling under my skin almost as I feel 
when I have smoked alot of pot.‖ (Zazaz, 2008; Erowid) 
Different 
routes of 
administrat
ion 
Pregabalin  
Intravenous 
―When the effects wore off, I decided to shoot one capsule. That was fantastic, I felt so good!! Now I 
will only use the lyrica IV. (it is perfect for injection, you empty the capsule in the cup.....you shoot a 
very pure solution)‖ (17) 
 
―I tried injecting it also. Almost all the powder inside the capsule is not water-soluble, but the 
pregabalin is very water soluble, so with a big cotton I was able to get a pretty damn clear solution 
outta there.…‖  (16). 
 
Rectal/plugging 
―SWIM (a 75kg male) … put the contents of a 75mg pregabalin capsule into water, and it didn't 
dissolve (which seems odd that pregabalin should be freely water soluble, but maybe more water 
would have been needed to dissolve all powder), but SWIM plugged the mixture…..Effects were felt 
after 5 minutes, were very close to the peak at 10 minutes, and did peak at 15 minutes. The effects 
seemed a bit more relaxing than usual, and it is hard to judge but SWIM would say that it shared a 
duration with oral administration and this dosage is equivalent to 150-300mg taken orally….‖ (15). 
 
―Swims used the drug rectally ….notices that its alot more soluble when the cap is opened first and 
the powder emptied out but if you dont want to go through the hassle hot water will easily dissolve 
the whole capsules. Just let it cool down a little before plugging.‖ (15). 
 
Parachuting 
―I just parachuted 2000 mgs of pregabalin powder. In two hours I'll see how f….d up I am. I have 
huge tolerance though…‖ (17)  
 
Gabapentin: oral; intramuscular 
 
Clonazepam: oral; crushed and eaten; snorting (grinding up the tablet and snort the mixture); 
intramuscular 
Tolerance Pregabalin 
―Lyrica has an extremely high ceiling. I‘m not suggesting you do 600+mg your first time, but I have 
taken amounts 3000+mgs[…] with Lyrica you gain tolerance extremely quickly.‖ (17). 
 
Gabapentin 
―..The most troubling thing about gapabentin was the tolerance level was very high. Each successive 
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dosing required more and more to achieve the same level. Doing gabapentin two days in a row was 
impossible....‖ (20) 
 
Clonazepam 
―...The benzo (clonazepam) created a very creative and almost 'giddy' type of reaction similar to 
most other benzodiazepines, except this time at a much lower dose and on a much more enjoyable 
level (especially considering my tollerance)…‖ (21) 
Use in 
combinatio
n with 
other 
substances 
 
 
Pregabalin is reportedly often taken in combination with other compounds in order to potentiate 
their effects, such as (4):   
 Alcohol 
 Prescribing drugs: benzodiazepines; zopiclone; gabapentin 
 Illicit/recreational drugs: hashish/marijuana; heroin/opiates; amphetamines; LSD.  
 ‗Legal highs‘: mephedrone/‘meow meow‘; Salvia divinorum 
 
Gabapentin:  
―…I love Gabapentin especially with Baclofen. 600-900mgs gives me a nice happy feeling, 1200mgs+ 
has me in an off buzz slightly reminiscent of MDMA…‖ (23). Other drugs reportedly taken in 
combination with gabapentin include: cannabis; alcohol; SSRIs; LSD; amphetamine; GHB. 
 
Clonazepam:  
Psychoactive drugs reportedly taken in combination include: mushrooms; MDMA; 2C-T-2; cannabis; 
nitrous oxide (24); alcohol; morning glory seeds (25) 
Illustrative 
examples 
of websites 
allegedly 
offering 
pregabalin
/gabapenti
n/clonazep
am for 
purchase 
(as of   
August 
2010)  
Pregabalin 
http://www.drugshoponline.com 
http://www.medrex-one.com 
http://www.ipharmacylist.com 
https://www.israelpharm.com 
http://www.canadadrugsonline.com 
http://www.medsupport.org 
http://www.eurodrugstore.eu 
http://www.easy.md 
 
Gabapentin 
http://www.pharmacyescrow.com/s4515-s-NEURONTIN.aspx 
http://www.77canadapharmacy.com/gabapentin.php 
http://www.omfgg.com/profiles/blogs/order-gabapentin-online-order 
http://firsthealthstore.net/products/neurontin.htm 
 
Clonazepam 
http://www.generictab.com  
http://www.buy-clonazepam.com  
http://www.coryholt.com   
http://www.elegantinteriorsanddesign.com   
Legenda: IMO: in my opinion; SWIM: somebody who is not me; DXM: dextromethorphan. Please note that although 
spelling mistakes have not been edited, rude words have been deleted. Most data collected from online forums that 
could be seen as personal identifiable (e.g. usernames, complete URLs for specific threads etc) were here 
appropriately anonymised. 
 
 
Discussion and Conclusions 
Pregabalin experimenters might be profiled here as individuals with a history of recreational 
polydrug misuse (14; 26). Pregabalin dosages most typically reported were clearly in excess 
(e.g. up to 5g) of the maximum level (e.g. 600 mg; 27-28) which is clinically advisable. If 
pregabalin is perceived by misusers to be a valid substitute for most common illicit sedative 
drugs, this may be a reason for concern.  
One could wonder about the anxiolytic properties of pregabalin, gabapentin and clonazepam as 
potential mediators for misuse. In fact, some users might start self administering with these 
GABA-ergic drugs as a way of self medicating. Because of rapid development of high tolerance 
levels with both pregabalin and gabapentin, then increasing dosages are self-administered. 
Consistently with this self medication hypothesis, some users advised either on the concurrent 
administration of pregabalin with gabapentin, or on their association with other sedatives, such 
as  alcohol, benzodiazepines and zopiclone.  
In line with observations here presented, pregabalin is indeed characterized by higher (2.5 
times; 29) potency; quicker absorption rates and greater bioavailability levels than gabapentin 
(30). One could wonder why both gabapentin and pregabalin, in apparent contrast with 
clonazepam, seem to possess both a sedative and a dissociative effect as well. Although all 
three compounds are GABA-ergic, pregabalin (31) and gabapentin (8; 32) precise mechanism 
of action is still unclear. Conversely, clonazepam is a well characterized, powerful  compound 
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which seem to have replaced flunitrazepam as the most popular misusing benzodiazepine (10).  
A better clarification of the pregabalin misuse potential level is of interest, since the drug has 
recently been proposed as a treatment for substance misuse, namely for both alcohol (33) and 
benzodiazepine dependent (34) individuals. Pregabalin potential of misuse is not typically 
mentioned in the prescribers‘ aides (e.g. 27; 35). However, controlled clinical studies carried 
out in over 5500 patients have shown that in some patient populations self-reporting rates of 
euphoria ranged between 1 and 12% (29). Abrupt/rapid discontinuation of pregabalin may be 
associated with insomnia, nausea, headache, or diarrhoea, which may be suggestive of 
physical dependence (36-37).  
One could wonder about the limitations of carrying out a risk of misuse assessment of a drug 
whilst taking into account the online comments only. In fact, it may be inappropriate to trust 
information obtained from the internet without independent verification. In April 2010, 
however, pregabalin has been included in the list of new recreational psychoactive substances 
officially notified to the relevant EU agencies (38). These concerns have recently been 
confirmed through analysis of the adverse drug reactions‘ Swedish national register data (39). 
Finally, pregabalin is a controlled substance under Schedule V of the United States' Controlled 
Substances Act.  
One could think that only large scale, adequately controlled, clinical studies can give a clear 
indication of drug characteristics and adverse effects. However, in line with present 
observations, previous studies from our group (40-41) have clearly suggested that increase in 
online trafficking/debate about a specific psychoactive drug typically precedes the occurrence 
of clinical incidents at the population level. As with any centrally active drug, physicians should 
carefully evaluate patients for history of drug abuse and observe them for signs of 
anticonvulsants‘, including pregabalin, misuse (37; 42). 
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